» Articles » PMID: 22319243

Adult Bone Marrow: Which Stem Cells for Cellular Therapy Protocols in Neurodegenerative Disorders?

Overview
Specialty Biology
Date 2012 Feb 10
PMID 22319243
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The generation of neuronal cells from stem cells obtained from adult bone marrow is of significant clinical interest in order to design new cell therapy protocols for several neurological disorders. The recent identification in adult bone marrow of stem cells derived from the neural crests (NCSCs) might explain the neuronal phenotypic plasticity shown by bone marrow cells. However, little information is available about the nature of these cells compared to mesenchymal stem cells (MSCs). In this paper, we will review all information available concerning NCSC from adult tissues and their possible use in regenerative medicine. Moreover, as multiple recent studies showed the beneficial effect of bone marrow stromal cells in neurodegenerative diseases, we will discuss which stem cells isolated from adult bone marrow should be more suitable for cell replacement therapy.

Citing Articles

EPO regulates neuronal differentiation of adult human neural-crest derived stem cells in a sex-specific manner.

Niemann T, Greiner J, Kaltschmidt C, Kaltschmidt B BMC Neurosci. 2023; 24(1):19.

PMID: 36879191 PMC: 9990360. DOI: 10.1186/s12868-023-00789-1.


Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment.

Kohli P, Otto E, Jahn D, Reisener M, Appelt J, Rahmani A Cells. 2021; 10(11).

PMID: 34831179 PMC: 8616497. DOI: 10.3390/cells10112955.


Are We Ready for Cell Therapy to Treat Stroke?.

Rascon-Ramirez F, Esteban-Garcia N, Barcia J, Trondin A, Nombela C, Sanchez-Sanchez-Rojas L Front Cell Dev Biol. 2021; 9:621645.

PMID: 34249901 PMC: 8260969. DOI: 10.3389/fcell.2021.621645.


Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials.

Bonilla C, Zurita M Biomedicines. 2021; 9(6).

PMID: 34200905 PMC: 8230536. DOI: 10.3390/biomedicines9060669.


Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches.

Schepici G, Silvestro S, Bramanti P, Mazzon E Medicina (Kaunas). 2020; 56(3).

PMID: 32204311 PMC: 7143935. DOI: 10.3390/medicina56030137.


References
1.
Li H, Say E, Zhou X . Isolation and characterization of neural crest progenitors from adult dorsal root ganglia. Stem Cells. 2007; 25(8):2053-65. DOI: 10.1634/stemcells.2007-0080. View

2.
Wislet-Gendebien S, Leprince P, Moonen G, Rogister B . Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci. 2003; 116(Pt 16):3295-302. DOI: 10.1242/jcs.00639. View

3.
Wislet-Gendebien S, Hans G, Leprince P, Rigo J, Moonen G, Rogister B . Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells. 2005; 23(3):392-402. DOI: 10.1634/stemcells.2004-0149. View

4.
Zhang Z, Wang X, Wang S . Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease. In Vitro Cell Dev Biol Anim. 2008; 44(5-6):169-77. DOI: 10.1007/s11626-008-9093-1. View

5.
Uccelli A, Benvenuto F, Laroni A, Giunti D . Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol. 2011; 24(1):59-64. DOI: 10.1016/j.beha.2011.01.004. View